CytoDyn Appoints Bruce Montgomery, M.D. to its Board of Directors
CytoDyn Inc. (“CytoDyn”) (OTC QB: CYDY), a biotechnology company focused on the development of new therapies for combating infection with immune deficiency viruses, today announced that A. Bruce Montgomery, M.D. has been appointed to the board of directors effective September 27, 2013.
Help employers find you! Check out all the jobs and post your resume.